Cargando…

A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus

INTRODUCTION: Children with congenital heart disease have complex medical and neurodevelopmental needs. We aimed to develop a multi-professional consensus-based referral pathway applicable to action the results of the brief developmental assessment (BDA), a validated early recognition tool, that cat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoskote, Aparna, Wray, Jo, Banks, Victoria, Brown, Katherine, Lakhanpaul, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204815/
https://www.ncbi.nlm.nih.gov/pubmed/32399503
http://dx.doi.org/10.1136/bmjpo-2019-000587
_version_ 1783530125790281728
author Hoskote, Aparna
Wray, Jo
Banks, Victoria
Brown, Katherine
Lakhanpaul, Monica
author_facet Hoskote, Aparna
Wray, Jo
Banks, Victoria
Brown, Katherine
Lakhanpaul, Monica
author_sort Hoskote, Aparna
collection PubMed
description INTRODUCTION: Children with congenital heart disease have complex medical and neurodevelopmental needs. We aimed to develop a multi-professional consensus-based referral pathway applicable to action the results of the brief developmental assessment (BDA), a validated early recognition tool, that categorises the neurodevelopmental status as green (appropriate for age), amber (equivocal) or red (delayed) in children aged between 4 months and 5 years. METHODS: A Delphi consensus survey detailing two scenarios—a child categorised as delayed (red) and another as equivocal (amber) on administration of the BDA at the time of discharge from the tertiary centre—was sent to 80 expert professionals from primary, secondary and tertiary care seeking agreement on next steps and referral pathways. An iterative process was proposed with a pre-defined rule of 75% for consensus. RESULTS: The survey was completed by 77 Delphi panel experts in Round 1, 73 in Round 2 and 70 in Round 3. Consensus was achieved (1) for the child with amber or red BDA, the child should be under the care of a paediatrician with expertise in cardiology (PEC) (or general paediatrician if no PEC) based at their local hospital, (2) for the child with red BDA, the PEC should initiate referral to community services at first assessment, (3) for child with amber BDA, a re-assessment by the health visitor should occur within 1–2 months, with referral to community services and notification to the PEC if on-going concerns. CONCLUSIONS: The Delphi process enabled a consensus to be reached between health professionals on referral pathways for specialist neurodevelopmental assessment/treatment for children with heart disease, in response to amber or red BDA results. The agreed referral pathway, if implemented, could underpin a national guideline to address and intervene on the neurodevelopmental difficulties in children with heart disease.
format Online
Article
Text
id pubmed-7204815
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72048152020-05-12 A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus Hoskote, Aparna Wray, Jo Banks, Victoria Brown, Katherine Lakhanpaul, Monica BMJ Paediatr Open Cardiology INTRODUCTION: Children with congenital heart disease have complex medical and neurodevelopmental needs. We aimed to develop a multi-professional consensus-based referral pathway applicable to action the results of the brief developmental assessment (BDA), a validated early recognition tool, that categorises the neurodevelopmental status as green (appropriate for age), amber (equivocal) or red (delayed) in children aged between 4 months and 5 years. METHODS: A Delphi consensus survey detailing two scenarios—a child categorised as delayed (red) and another as equivocal (amber) on administration of the BDA at the time of discharge from the tertiary centre—was sent to 80 expert professionals from primary, secondary and tertiary care seeking agreement on next steps and referral pathways. An iterative process was proposed with a pre-defined rule of 75% for consensus. RESULTS: The survey was completed by 77 Delphi panel experts in Round 1, 73 in Round 2 and 70 in Round 3. Consensus was achieved (1) for the child with amber or red BDA, the child should be under the care of a paediatrician with expertise in cardiology (PEC) (or general paediatrician if no PEC) based at their local hospital, (2) for the child with red BDA, the PEC should initiate referral to community services at first assessment, (3) for child with amber BDA, a re-assessment by the health visitor should occur within 1–2 months, with referral to community services and notification to the PEC if on-going concerns. CONCLUSIONS: The Delphi process enabled a consensus to be reached between health professionals on referral pathways for specialist neurodevelopmental assessment/treatment for children with heart disease, in response to amber or red BDA results. The agreed referral pathway, if implemented, could underpin a national guideline to address and intervene on the neurodevelopmental difficulties in children with heart disease. BMJ Publishing Group 2020-04-21 /pmc/articles/PMC7204815/ /pubmed/32399503 http://dx.doi.org/10.1136/bmjpo-2019-000587 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiology
Hoskote, Aparna
Wray, Jo
Banks, Victoria
Brown, Katherine
Lakhanpaul, Monica
A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus
title A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus
title_full A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus
title_fullStr A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus
title_full_unstemmed A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus
title_short A referral pathway for potentially abnormal neurodevelopment in children with heart disease in the United Kingdom: a Delphi consensus
title_sort referral pathway for potentially abnormal neurodevelopment in children with heart disease in the united kingdom: a delphi consensus
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204815/
https://www.ncbi.nlm.nih.gov/pubmed/32399503
http://dx.doi.org/10.1136/bmjpo-2019-000587
work_keys_str_mv AT hoskoteaparna areferralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT wrayjo areferralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT banksvictoria areferralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT brownkatherine areferralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT lakhanpaulmonica areferralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT hoskoteaparna referralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT wrayjo referralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT banksvictoria referralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT brownkatherine referralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus
AT lakhanpaulmonica referralpathwayforpotentiallyabnormalneurodevelopmentinchildrenwithheartdiseaseintheunitedkingdomadelphiconsensus